Skip to main content Skip to navigation
We care about your privacy. Read about your rights and how we protect your data. Get Details

Resources for Providers

Diagnosis and Management of Celiac Disease

Diagnosis of celiac disease is typically twofold – first, elevated levels of tissue transglutaminase IgA (tTG-IgA) are detected by serology. The diagnosis is confirmed upon duodenal mucosal biopsies.  For patients demonstrating IgA deficiency, IgG-based testing should be performed (e.x., tTG-IgG).  For a full discussion on the details of celiac disease diagnosis, please refer to these guidelines. As a secondary reference, you may review the American College of Gastroenterology (ACG) clinical guidelines.

Our Program History

John D. Synder, M.D. (1947-2016) was the first Medical Director of the Celiac Disease Program at Children’s National Hospital at its inception in 2009. Tragically, he passed away suddenly after sustaining a critical injury during a cycling accident in France. Before his death, he significantly expanded the breadth of services offered by Children’s National. Dr. Snyder also left guidance in a much-needed report on how to manage celiac disease in children. This article is now considered to be the central set of recommendations for follow-up care in pediatric celiac disease.

Continuing Education

The Celiac Disease Program at Children’s National Hospital is proud to offer a selection of Continuing Education (CE) and Continuing Medical Education (CME) for providers who care for patients with celiac disease.  To access these courses, please choose from the selection below: